Cited by 2,712Inflammatory Bowel DiseaseOcular Diseases and Behçet’s SyndromeAutoimmune and Inflammatory Disorders

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Inflammatory Bowel Disease

Open access

Abraham, Clara, Cho, Judy H.·2009·New England Journal of Medicine

Open this paper in CoChat — free account Open PDF

Abstract

more than 50 distinct clinical collections, which can be used as convenient entry points to clinical content.In each collection, articles are cited in reverse chronologic order, with the most recent first.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmra0804647

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S. K., Wise, R. P., Mirabile‐Levens, E., Kasznica, J. M., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,683
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554

Show all 104 references

Research works printed but not linked: 6

Musch MW, 2002, J Clin Invest, 110, 1739, 10.1172/JCI0215695 · DOI
Vijay-Kumar M, 2007, J Clin Invest, 117, 3909
10.1172/JCI19229 · DOI
Kamada N, 2008, J Clin Invest, 118, 2269
Watanabe T, 2008, J Clin Invest, 118, 545
Sugimoto K, 2008, J Clin Invest, 118, 534

Sorted by citations

Items 701–800 of 1,008

Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women
Li, W., Cho, E., Khalili, H., Wu, S., Chan, A. T., & Qureshi, A. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.09.013 · Cited by 52
“CD and UC display varied cytokine profiles.(7,8) The genetic disposition of CD and UC may also be different.”
Background
High Residential Sun Exposure Is Associated With a Low Risk of Incident Crohnʼs Disease in the Prospective E3N Cohort
Jantchou, P., Clavel‐Chapelon, F., Racine, A., Kvaskoff, M., Carbonnel, F., & Boutron‐Ruault, M. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000436275.12131.4f · Cited by 52
Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease
Bamias, G., Kaltsa, G., Siakavellas, S. I., Gizis, M., Margantinis, G., Zampeli, E., Vafiadis-Zoumboulis, I., Michopoulos, S., Daikos, G. L., & Ladas, S. D. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.09.002 · Cited by 52
CD69 Is the Crucial Regulator of Intestinal Inflammation: A New Target Molecule for IBD Treatment?
Radulovic, K., & Niess, J. H. (2015) · Journal of Immunology Research · doi:10.1155/2015/497056 · Cited by 56
Randomized, Controlled Trial of Budesonide and Prednisone for the Treatment of Idiopathic Inflammatory Bowel Disease in Dogs
Dye, T. L., Diehl, K. J., Wheeler, S. L., & Westfall, D. S. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12195 · Cited by 52
MTMR3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activation
Lahiri, A., Hedl, M., & Abraham, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501752112 · Cited by 52
Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
Catalán‐Serra, I., & Brenna, Ø. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1461297 · Cited by 54
Increased Risk of Ulcerative Colitis in Patients with Periodontal Disease: A Nationwide Population-Based Cohort Study
Lin, C., Tseng, K.-S., Liu, J., Chuang, H.-C., Lien, C.-H., Chen, Y.-C., Lai, C.-Y., Yu, C., & Hsu, R. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15112602 · Cited by 51
Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
Bourgonje, A. R., Gabriëls, R. Y., de Borst, M. H., Bulthuis, M. L. C., Faber, K. N., van Goor, H., & Dijkstra, G. D. H. (2019) · Antioxidants · doi:10.3390/antiox8090351 · Cited by 52
Idebenone Protects against Acute Murine Colitis via Antioxidant and Anti-Inflammatory Mechanisms
Shastri, S., Shinde, T., Sohal, S. S., Gueven, N., & Eri, R. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020484 · Cited by 52
Chemistry meets biology in colitis-associated carcinogenesis
Mangerich, A., Dedon, P. C., Fox, J. G., Tannenbaum, S. R., & Wogan, G. N. (2013) · Free Radical Research · doi:10.3109/10715762.2013.832239 · Cited by 51
An immunological link betweenCandida albicanscolonization and Crohn’s disease
Gérard, R., Sendid, B., Colombel, J., Poulain, D., & Jouault, T. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.810587 · Cited by 51
Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis
Shi, F., Guo, X., Jiang, X., Zhou, P., Xiao, Y., Zhou, T., Chen, G., Zhao, Z. J., He, X., Hou, C., et al. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.09.001 · Cited by 52
Selenium, Selenoprotein Genes and Crohn’s Disease in a Case-Control Population from Auckland, New Zealand
Gentschew, L., Bishop, K. S., Han, D. Y., Morgan, A. R., Fraser, A. G., Lam, W. J., Karunasinghe, N., Campbell, B., & Ferguson, L. R. (2012) · Nutrients · doi:10.3390/nu4091247 · Cited by 51
Tissue-resident dendritic cells and diseases involving dendritic cell malfunction
Chen, K., Wang, J., Yuan, R., Xiang, Y., Li, L., Gong, W., Yang, T., Li, L., & Su, S. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.007 · Cited by 51
Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease
Minar, P., Saeed, S. A., Afreen, M., Kim, M., & Denson, L. A. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001029 · Cited by 51
Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations
Law, C. C. Y., Sasidharan, S., Rodrigues, R., Nguyen, D. D., Sauk, J. S., Garber, J. J., Giallourakis, C. C., Xavier, R. J., Khalili, H., Yajnik, V., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000870 · Cited by 51
mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile
Hu, S., Chen, M., Wang, Y., Wang, Z., Pei, Y.-F., Fan, R., Liu, X., Wang, L., Zhou, J., Zheng, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154564 · Cited by 56
Preconditioning Enhances the Therapeutic Effects of Mesenchymal Stem Cells on Colitis Through PGE2-Mediated T-Cell Modulation
Yang, F. Y., Chen, R., Zhang, X., Huang, B., Tsang, L. L., Li, X., & Jiang, X. (2018) · Cell Transplantation · doi:10.1177/0963689718780304 · Cited by 51
Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn’s Disease and Ulcerative Colitis: A Mendelian Randomization Study
Georgiou, A. N., Ntritsos, G., Papadimitriou, N., Dimou, N. L., & Εvangelou, Ε. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa152 · Cited by 52
“2, 3 The mechanism triggering IBDs involves the inappropriate inflammatory response to intestinal microbes, which is mediated by the complex interplay between genetic susceptibility, environmental factors, and microbial dysbiosis.”
Background
Methods in microbiome research: Past, present, and future
Gotschlich, E. C., Colbert, R. A., & Gill, T. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101498 · Cited by 58
The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity
Kuchroo, J. R., Hafler, D. A., Sharpe, A. H., & Lucca, L. E. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf4034 · Cited by 51
Maintaining Intestinal Health: The Genetics and Immunology of Very Early Onset Inflammatory Bowel Disease
Kelsen, J. R., Baldassano, R. N., Artis, D., & Sonnenberg, G. F. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.06.010 · Cited by 53
Cytomegalovirus Enhances Macrophage TLR Expression and MyD88-Mediated Signal Transduction To Potentiate Inducible Inflammatory Responses
Smith, P. D., Shimamura, M., Musgrove, L. C., Dennis, E. A., Bimczok, D., Novak, L., Ballestas, M. E., Fenton, A. N., Dandekar, S., Britt, W. J., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302608 · Cited by 50
Circulating Microparticles from Crohn’s Disease Patients Cause Endothelial and Vascular Dysfunctions
Leonetti, D., Reimund, J., Tesse, A., Viennot, S., Martínez, M. C., Bretagne, A. L. B., & Andriantsitohaina, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073088 · Cited by 50
Colon-Targeted Cell-Permeable NFκB Inhibitory Peptide Is Orally Active against Experimental Colitis
Hong, S., Yum, S., Yoo, H., Kang, S., Yoon, J.-H., Min, D., Kim, Y. M., & Jung, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200591q · Cited by 50
Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease
Chinnadurai, R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i16.4779 · Cited by 50
DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function
Zhao, J., Shi, P., Sun, Y., Sun, J., Dong, J., Wang, H., Zuo, L., Gong, J., Li, Y., Gu, L., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001294 · Cited by 50
Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells
Franzè, E., Marafini, I., Simone, V. D., Monteleone, I., Caprioli, F., Colantoni, A., Ortenzi, A., Crescenzi, F., Izzo, R., Sica, G. S., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv181 · Cited by 50
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD)
Gadaleta, R. M., García‐Irigoyen, O., & Moschetta, A. (2017) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.20 · Cited by 50
Shear stress induces noncanonical autophagy in intestinal epithelial monolayers
Kim, S. W., Ehrman, J. D., Ahn, M., Kondo, J., Lopez, A. A., Oh, Y. S., Kim, X. H., Crawley, S. W., Goldenring, J. R., Tyska, M. J., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-01-0021 · Cited by 52
Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review
Zeng, W., He, D., Xing, Y., Liu, J., Su, N., Zhang, C., Wang, Y., & Xing, X. (2021) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.02.016 · Cited by 53
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice
Lee, H., Jung, K. B., Kwon, O., Son, Y. S., Choi, E., Yu, W. D., Son, N., Jeon, J. H., Jo, H., Yang, H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2121580 · Cited by 52
Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease
Orlando, A., Guglielmi, F., Cottone, M., Orlando, E., Romano, C., & Sinagra, E. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.07.005 · Cited by 49
Preventive effects of cranberry products on experimental colitis induced by dextran sulphate sodium in mice
Xiao, X., Kim, J., Sun, Q., Kim, D., Park, C., Lu, T., & Park, Y. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.07.006 · Cited by 49
Dietary Ganglioside Reduces Proinflammatory Signaling in the Intestine
Miklavcic, J. J., Schnabl, K. L., Mazurak, V. C., Thomson, A. B. R., & Clandinin, M. T. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/280286 · Cited by 49
Improved risk prediction for Crohn's disease with a multi-locus approach
Kang, J., Kugathasan, S., Georges, M., Zhao, H., & Cho, J. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr116 · Cited by 50
“The pathogenesis of Crohn’s disease is multifactorial and includes a strong genetic component (2).”
Background
Proinflammatory Progranulin Antibodies in Inflammatory Bowel Diseases
Thurner, L., Stöger, E., Fadle, N., Klemm, P., Regitz, E., Kemele, M., Bette, B., Held, G., Dauer, M., Lammert, F., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3089-3 · Cited by 49
Role of the TWEAK/Fn14 pathway in autoimmune diseases
Xu, W., Zhao, Y., & Liu, Y. (2015) · Immunologic Research · doi:10.1007/s12026-015-8761-y · Cited by 49
Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases
Park, T.-Y., Jang, Y., Kim, W., Shin, J. S., Toh, H. T., Kim, C., Yoon, H. S., Leblanc, P. R., & Kim, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-52085-w · Cited by 49
The risk of cardiovascular complications in inflammatory bowel disease
Czubkowski, P., Osiecki, M., Szymańska, E., & Kierkuś, J. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00639-y · Cited by 49
Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori
Gorlé, N., Bauwens, E., Haesebrouck, F., Smet, A., & Vandenbroucke, R. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584165 · Cited by 49
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease
Gjuladin-Hellon, T., Iheozor‐Ejiofor, Z., Gordon, M. A., & Akobeng, A. K. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010233.pub3 · Cited by 50
The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature
Vakadaris, G., Stefanis, C., Giorgi, E., Brouvalis, M., Voidarou, C. C., Kourkoutas, Y., Tsigalou, C., & Bezirtzoglou, E. (2023) · Biomedicines · doi:10.3390/biomedicines11020494 · Cited by 54
25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn’s disease
Bartels, L. E., Jørgensen, S. P., Bendix, M., Hvas, C. L., Agnholt, J. S., Agger, R., & Dahlerup, J. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-012-0168-y · Cited by 47
Pediatric ulcerative colitis associated with autoimmune diseases: A distinct form of inflammatory bowel disease?
Ordonez, F., Lacaille, F., Canioni, D., Talbotec, C., Fournet, J., Cerf–Bensussan, N., Goulet, O., Schmitz, J., & Ruemmele, F. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22864 · Cited by 49
A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease
Farzaei, M. H., Bahramsoltani, R., Abdolghaffari, A. H., Sodagari, H. R., Esfahani, S. A., & Rezaei, N. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1145546 · Cited by 50
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States
Patel, H., Lissoos, T. W., & Rubin, D. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175099 · Cited by 48
The Natural History of IBD: Lessons Learned
Weimers, P., & Munkholm, P. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0173-3 · Cited by 49
Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice
Kim, D. H., Kim, S., Ahn, J. B., Kim, J. H., Woo, H. J., Seo, D. H., Che, X., Park, K. C., Jeon, J. Y., Kim, S. Y., et al. (2020) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2020.151391 · Cited by 48
“Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn’s disease (CD), are chronic relapsing inflammatory disorders of the gastrointestinal tract (Abraham and Cho, 2009).”
Background
Sleep and Fatigue in IBD: an Unrecognized but Important Extra-intestinal Manifestation
Canakis, A., & Qazi, T. (2020) · Current Gastroenterology Reports · doi:10.1007/s11894-020-0746-x · Cited by 47
The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer
Bocchetti, M., Ferraro, M. G., Ricciardiello, F., Ottaiano, A., Luce, A., Cossu, A. M., Scrima, M., Leung, W. Y., Abate, M., Stiuso, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083967 · Cited by 48
Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study
Tsai, S., Chen, H.-J., Lio, C.-F., Kuo, C.-F., Kao, A.-C., Wang, W.-S., Yao, W.-C., Chen, C., & Yang, T.-Y. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1797-3 · Cited by 47
Limonin ameliorates dextran sulfate sodium-induced chronic colitis in mice by inhibiting PERK-ATF4-CHOP pathway of ER stress and NF-κB signaling
Song, C., Chen, J., Li, X., Yang, R., Cao, X., Zhou, L., Zhou, Y., Ying, H., Zhang, Q., & Sun, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107161 · Cited by 49
Tyro3, Axl, and Mertk Receptor Signaling in Inflammatory Bowel Disease and Colitis-associated Cancer
Rothlin, C. V., Leighton, J. A., & Ghosh, S. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000050 · Cited by 48
Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis
Bellavia, M., Tomasello, G., Romeo, M., Damiani, P., Monte, A. I. L., Lozio, L., Campanella, C., Marino, A., Rappa, F., Zummo, G., et al. (2013) · Medical Microbiology and Immunology · doi:10.1007/s00430-013-0305-2 · Cited by 47
Evaluation of 22 genetic variants with Crohn's Disease risk in the Ashkenazi Jewish population: a case-control study
the New York Crohn's Disease Working Group, Peter, I., Mitchell, A. A., Ozelius, L. J., Erazo, M., Hu, J., Doheny, D. O., Abreu, M. T., Present, D. H., Ullman, T. A., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-63 · Cited by 47
The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis
Reinecke, K., Eminel, S., Dierck, F., Roessner, W., Kersting, S., Chromik, A. M., Gavrilova, O., Laukevicience, A., Leuschner, I., Waetzig, V., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030985 · Cited by 49
Inflammatory bowel diseases increase future ischemic stroke risk: A Taiwanese population-based retrospective cohort study
Huang, W.-S., Tseng, C., Chen, P., Tsai, C., Lin, C., Sung, F., & Kao, C. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.05.009 · Cited by 47
Optimal vitamin D levels in Crohn's disease: a review
Raftery, T. C., & OʼSullivan, M. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114001591 · Cited by 47
Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease
Brown, M., Hughes, K. R., Moossavi, S., Robins, A., & Mahida, Y. R. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12381 · Cited by 47
Intestinal anti-inflammatory activity of goat milk and goat yoghurt in the acetic acid model of rat colitis
de Assis, P. O. A., de Andrade, L. D. F. L. I., Guerra, G. C. B., Araújo, D. F. D. S., Júnior, R. F. D. A., Machado, T. A. D. G., de Araújo, A. A., de Lima, T. A. S., García, H., & Queiroga, R. D. C. R. D. E. (2015) · International Dairy Journal · doi:10.1016/j.idairyj.2015.11.002 · Cited by 47
Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission
Palone, F., Vitali, R., Cucchiara, S., Mennini, M., Armuzzi, A., Pugliese, D., Renata D'Incà, Barberio, B., & Stronati, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000938 · Cited by 46
Oral administration of curcumin attenuates visceral hyperalgesia through inhibiting phosphorylation of TRPV1 in rat model of ulcerative colitis
Yang, M., Wang, J., Yang, C., Han, H., Rong, W., & Zhang, G. (2017) · Molecular Pain · doi:10.1177/1744806917726416 · Cited by 47
The cholinergic anti‐inflammatory pathway revisited
Murray, K. D., & Reardon, C. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13288 · Cited by 48
Is-there a place for vagus nerve stimulation in inflammatory bowel diseases?
Bonaz, B. L. (2018) · Bioelectronic Medicine · doi:10.1186/s42234-018-0004-9 · Cited by 48
RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation
Wong, J., Garcia‐Carbonell, R., Zelic, M., Ho, S. B., Boland, B. S., Yao, S.-J., Desai, S. A., Das, S., Planell, N., Harris, P. A., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.10.002 · Cited by 49
Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis
Kedia, S., Ghosh, T. S., Jain, S., Desigamani, A., Kumar, A., Gupta, V., Bopanna, S., Yadav, D. P., Goyal, S., Makharia, G. K., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15232 · Cited by 49
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease
Naganuma, M., Fujii, T., & Watanabe, M. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0352-z · Cited by 47
Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease
Yasutomi, Y., Chiba, A., Haga, K., Murayama, G., Makiyama, A., Kuga, T., Watanabe, M., Okamoto, R., Nagahara, A., Nagaishi, T., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.018 · Cited by 47
Gut Virome: Role and Distribution in Health and Gastrointestinal Diseases
Spencer, L. A., Olawuni, B., & Singh, P. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.836706 · Cited by 46
Ulcerative colitis-induced hepatic damage in mice: Studies on inflammation, fibrosis, oxidative DNA damage and GST-P expression
Trivedi, P. P., & Jena, G. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.12.004 · Cited by 46
Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation
Limketkai, B. N., Bayless, T. M., Brant, S. R., & Hutfless, S. M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12845 · Cited by 47
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages
Rizzo, A., Monteleone, I., Fina, D., Stolfi, C., Caruso, R., Fantini, M. C., Franzè, E., Schwendener, R. A., Pallone, F., & Monteleone, G. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21799 · Cited by 46
Assessment of Inflammation in an Acute on Chronic Model of Inflammatory Bowel Disease with Ultrasound Molecular Imaging
Machtaler, S., Knieling, F., Luong, R. H., Tian, L., & Willmann, J. K. (2015) · Theranostics · doi:10.7150/thno.13048 · Cited by 46
Ustekinumab in treatment of Crohn’s disease: design, development, and potential place in therapy
Deepak, P., & Loftus, E. V. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s102141 · Cited by 47
Role of endoscopy in inflammatory bowel disease
Bharadwaj, S., Narula, N., Tandon, P., & Yaghoobi, M. (2018) · Gastroenterology report · doi:10.1093/gastro/goy006 · Cited by 46
Healing of Apical Periodontitis in Patients with Inflammatory Bowel Diseases and under Anti–tumor Necrosis Factor Alpha Therapy
Cotti, E., Mezzena, S., Schirru, E., Ottonello, O., Mura, M., Ideo, F., Susnik, M., & Usai, P. (2018) · Journal of Endodontics · doi:10.1016/j.joen.2018.09.004 · Cited by 47
Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?
Strowitzki, M. J., Ritter, A. S., Kimmer, G., & Schneider, M. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104364 · Cited by 47
Orthogonally oriented scaffolds with aligned fibers for engineering intestinal smooth muscle
Kobayashi, M., Lei, N., Wang, Q., Wu, B. M., & Dunn, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.023 · Cited by 46
The kiwi fruit peptide kissper displays anti-inflammatory and anti-oxidant effects inin-vitroandex-vivohuman intestinal models
Ciacci, C., Russo, I., Bucci, C., Iovino, P., Pellegrini, L., Giangrieco, I., Tamburrini, M., & Ciardiello, M. A. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12229 · Cited by 47
Role of the advanced glycation end products receptor in Crohn’s disease inflammation
Ciccocioppo, R. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i45.8269 · Cited by 47
Hydroxylases as therapeutic targets in inflammatory bowel disease
Cummins, E. P., Doherty, G. A., & Taylor, C. T. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.9 · Cited by 45
A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model
Park, J., Choi, J., Kwon, J. Y., Jung, K., Yang, C. W., Park, S., & Cho, M. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1410-1 · Cited by 46
Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn’s Disease
Zhuang, X., Tian, Z., Feng, R., Li, M., Li, T., Zhou, G., Qiu, Y., Chen, B., He, Y., Chen, M., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa253 · Cited by 47
“Exclusion criteria were (1) age <18 years, (2) had received antibiotics or probiotics within the previous 4 weeks, (3) diagnosis of IBD rather than CD, and (4) pregnancy or lactation status.”
BackgroundMethod
Frailty in inflammatory bowel diseases: an emerging concept
Kochar, B. D., Orkaby, A. R., Ananthakrishnan, A. N., & Ritchie, C. S. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211025474 · Cited by 45
Rheumatoid arthritis and inflammatory bowel disease: A bidirectional two-sample Mendelian randomization study
Meisinger, C., & Freuer, D. (2022) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2022.151992 · Cited by 45
Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease
Zhang, H., Kalla, R., Chen, J., Zhao, J., Zhou, X., Adams, A. T., Noble, A. J., Ventham, N. T., Wellens, J., Ho, G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44841-y · Cited by 50
Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis
Zhao, X., Fan, J., Zhi, F., Li, A., Li, C., Berger, A. E., Boorgula, M. P., Barkataki, S., Courneya, J.-P., Chen, Y., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv192 · Cited by 44
The Risk of Malignancy Associated with the Use of Biological Agents in Patients with Inflammatory Bowel Disease
Dulai, P. S., & Siegel, C. A. (2014) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2014.05.010 · Cited by 44
Targets for new immunomodulation strategies in inflammatory bowel disease
Monteleone, G., Caruso, R., & Pallone, F. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.06.003 · Cited by 44
Genetic Deletion of Tissue Inhibitor of Metalloproteinase-1/TIMP-1 Alters Inflammation and Attenuates Fibrosis in Dextran Sodium Sulphate-induced Murine Models of Colitis
Breynaert, C. M., de Bruyn, M., Arijs, I., Cremer, J., Martens, E., Lommel, L. V., Geboes, K. J., Hertogh, G. D., Schuit, F. C., Ferrante, M., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw101 · Cited by 44
NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells
Negroni, A., Colantoni, E., Vitali, R., Palone, F., Pierdomenico, M., Costanzo, M., Cesi, V., Cucchiara, S., & Stronati, L. (2016) · Inflammation Research · doi:10.1007/s00011-016-0964-8 · Cited by 47
“Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic polygenic immune disorders with complex multifactor etiology that affect the gastrointestinal tract [11].”
Background
MiR-155 contributes to Th17 cells differentiation in dextran sulfate sodium (DSS)-induced colitis mice via Jarid2
Xu, M., Zuo, D., Liu, X., Fan, H., Chen, Q., Deng, S., Shou, Z., Tang, Q., Yang, J., Nan, Z., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.143 · Cited by 44
6-Formylindolo(3,2-b)carbazole induced aryl hydrocarbon receptor activation prevents intestinal barrier dysfunction through regulation of claudin-2 expression
Ma, Y., Wang, Q., Yu, K., Fan, X., Xiao, W., Cai, Y., Xu, P., Yu, M., & Yang, H. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.04.020 · Cited by 44
The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview
M’Koma, A. E. (2018) · Gastrointestinal Disorders · doi:10.3390/gidisord1010007 · Cited by 46
Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity
Ribaldone, D. G., Brigo, S., Mangia, M., Saracco, G. M., Astegiano, M., & Pellicano, R. (2020) · Medicines · doi:10.3390/medicines7060033 · Cited by 44
Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn’s Disease: Results From a Large Electronic Medical Record-derived Cohort
Kurowski, J. A., Milinovich, A., Ji, X., Bauman, J. M., Sugano, D., Kattan, M. W., & Achkar, J. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa239 · Cited by 44
Delays in Puberty, Growth, and Accrual of Bone Mineral Density in Pediatric Crohn’s Disease: Despite Temporal Changes in Disease Severity, the Need for Monitoring Remains
DeBoer, M. D., & Denson, L. A. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.02.010 · Cited by 46
“C rohn’s disease (CD) is an immune-mediated process causing injury to the small intestinal and colonic mucosa, leading to local and systemic inflammation.(1) Although hallmarked by symptoms such as weight loss, abdominal pain, and bloody diarrhea, CD can have an insidious onset that escapes clinical detection.”
Background
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis
Antonioli, L., Fornai, M., Colucci, R., Awwad, O., Ghisu, N., Tuccori, M., Tacca, M. D., & Blandizzi, C. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.041 · Cited by 45

Authors: Abraham, C., & Cho, J. H.
Affiliations: Yale University (US)
ORCID: Abraham, Clara
Cho, Judy H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2009-11-19
Volume: 361
Issue: 21
Pages: 2066-2078
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra0804647
PMC: PMC3491806
OpenAlex: W4244626580
Cited by: 2,712
References: 104
Citations by year: 2026: 94 · 2025: 137 · 2024: 169 · 2023: 151 · 2022: 171 · 2021: 184 · 2020: 237 · 2019: 189 · 2018: 193 · 2017: 182 · 2016: 171 · 2015: 217 · 2014: 174 · 2013: 142 · 2012: 120
FWCI: 9.21
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Crohn's and Colitis Foundation of America (DK062422, R01DK077905)
Crohn's and Colitis Foundation
National Institutes of Health (DK P30-34989, U01 DK62429)
Takeda Oncology
National Institute of Diabetes and Digestive and Kidney Diseases (DK P30 34989, U01-DK62429, R01DK072373, R01DK077905, RC1DK086800, U01DK062429, P30DK034989, U01DK062422)
National Center for Research Resources (UL1RR024139)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Health Sciences › Medicine › Dermatology › Autoimmune and Inflammatory Disorders
Keywords: inflammatory bowel disease
MeSH terms: Animals, Colitis, Ulcerative, Crohn Disease, Humans, Immunity, Innate, Intestinal Mucosa, T-Lymphocytes, Inflammatory Bowel Diseases, Interleukin-23, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammatory Bowel Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks